Capabilities

Services

Cell models

Companies in our biotechnology incubator receive live cultures by hand. No shipping, no cold chain, no transit time.

Dual-SMAD inhibition, minimal patterning. Mixed dorsal forebrain identity, higher cell-type diversity, higher batch variance.

Patterned dorsal forebrain. SOX2+ ventricular zones, CTIP2+ deep-layer neurons by day 60. Lower variance than semi-guided.

Ventralized with SHH agonist. NKX2-1+ progenitors, GAD67+ interneurons. Fusible with dorsal organoids for migration assays.

Wnt-modulated differentiation, lactate selection. >90% cTnT+, ventricular MLC2v+ subtype. Delivered live or cryopreserved.

Reprogramming from 3 mm skin biopsy or 8 mL blood. 3 clones per donor, karyotype, STR match, pluripotency panel, mycoplasma clearance.

NGN2 induction or dual-SMAD NPC route. MAP2+/TUJ1+ cultures, MEA-ready plating on request.

QC, alignment, gene-level quantification, differential expression, pathway enrichment. Code and counts matrices delivered.

Junction-level outlier detection against a control cohort. Reports exon skipping, intron retention, cryptic splice sites with per-event read support.

Long-read or hybrid assembly of full-length transcripts. Per-isoform abundance and ORF impact.

Ambient RNA and doublet removal, integration, clustering, annotation against reference atlases, compositional testing.

40–80 candidates per target: gapmer or splice-switching, off-target screen against the human transcriptome, ranked tiling.